HK40128362A - 用於治疗肺纤维化的metap2抑制剂 - Google Patents

用於治疗肺纤维化的metap2抑制剂

Info

Publication number
HK40128362A
HK40128362A HK62025116706.5A HK62025116706A HK40128362A HK 40128362 A HK40128362 A HK 40128362A HK 62025116706 A HK62025116706 A HK 62025116706A HK 40128362 A HK40128362 A HK 40128362A
Authority
HK
Hong Kong
Prior art keywords
treatment
pulmonary fibrosis
metap2 inhibitors
metap2
inhibitors
Prior art date
Application number
HK62025116706.5A
Other languages
English (en)
Inventor
Peter Cornelius
Bradley J. CARVER
Sebastien Labbe
James Shanahan
Original Assignee
Syndevrx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syndevrx, Inc. filed Critical Syndevrx, Inc.
Publication of HK40128362A publication Critical patent/HK40128362A/zh

Links

HK62025116706.5A 2022-08-10 2023-08-10 用於治疗肺纤维化的metap2抑制剂 HK40128362A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263396836P 2022-08-10
US202263405973P 2022-09-13

Publications (1)

Publication Number Publication Date
HK40128362A true HK40128362A (zh) 2026-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4028013A4 (en) MRSA1 INHIBITORS
EP3917516A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
CA3264343A1 (en) METAP2 INHIBITORS FOR THE TREATMENT OF PULMONARY FIBROSIS
CA3277368A1 (en) Phosphoglicerate dehydrogenase inhibitors for the treatment of fibrosis
CA3277401A1 (en) Phosphoglicerate dehydrogenase inhibitors for the treatment of fibrosis
EP4069216A4 (en) COMPOUNDS AND METHODS FOR TREATING CYSTIC FIBROSIS
HK40115372A (zh) 布罗替德用於治疗特发性肺纤维化的用途
CA3308736A1 (en) The use of enolase inhibitor pomhex for treatment of fibrosis
HK40091278A (zh) 治疗肺纤维化的方法
EP3960171A4 (en) USE OF AN ADAM9 INHIBITOR AS AN IMMUNOMODULATOR
AU2020901743A0 (en) Methods of treating pulmonary fibrosis
CA3289747A1 (en) Methods of treating pulmonary fibrosis
AU2023901558A0 (en) Methods of treating pulmonary fibrosis
AU2024408031A1 (en) Oxo-pyridine derivatives as inhibitors of transglutaminases for use in the treatment of pulmonary fibrosis
CA3310641A1 (en) Oxo-pyridine derivatives as inhibitors of transglutaminases for use in the treatment of pulmonary fibrosis
CA3308179A1 (en) Londamocitinib for the treatment of asthma
HK40099578A (zh) 治疗纤维化的方法
CA3283855A1 (en) Methods of treating fibrosis
HK40109702A (zh) 用於治疗冠状病毒感染的蛋白酶抑制剂
HK40119787A (zh) 治疗纤维化的方法
CA3293703A1 (en) Methods for treatment of pulmonary hypertension
CA3289184A1 (en) Heteroarylindole inhibitors of apol-1
AU2023901140A0 (en) Inhibition of coronavirus
HK40117134A (zh) 用於肺高压的治疗的曲前列环素
AU2022901004A0 (en) Inhibition of coronavirus